[1] GUO S J, JIANG D J, LI Z L, et al. Research progress on relationship between intestinal flora and common gastrointestinal diseases and treatments of Chinese materia medica and microecological preparations. Chin Tradit Herb Drugs (中草药), 2018, 49(18): 4424-4431.
[2] DEWEERDT S. Aetiology: crucial clues. Nature, 2014, 513(7517): 12-13.
[3] VANDEPUTTE D, FALONY G, VIEIRA-SILVA S, et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut, 2015, 65: 57-62.DOI:10.1136/gutjnl-2015-309618.
[4] PAN G F, ZHANG L D, FENG Z X, et al. Prevention and treatment of gut microbiota related colorectal cancer by traditional Chinese medicine. Electron J Metab Nutr Cancer (肿瘤代谢与营养电子杂志), 2018, 5: 97-101. DOI:10.16689/j.cnki.cn11-9349/r.2018.01.020.
[5] CAO W Y, FENG B, WANG X J. Research progress on the metabolism of natural saponins by intestinal flora/hepatic drug enzymes. J China Pharm (中国药房), 2016, 27(28): 3999-4002.
[6] SONNENBURG J L, BACKHED F. Diet-microbiota interactions as moderators of human metabolism. Nature, 2016, 535(7610): 56-64.
[7] XIE J R, ZHANG Y. Research progress in intestinal flora imbalance-related chronic diarrhea treated by TCM. Chin J Inf Tradit Chin Med (中国中医药信息杂志), 2019, 26(2): 141-144.
[8] CHENG J W, LIU W E, MA X J, et al. Expert consensus on diagnosis and treatment of Clostridium difficile infection in Chinese adults. Med J Peking Union Med Coll Hosp (协和医学杂志), 2017, 8(Suppl. 1): 131-138.
[9] ZHANG Z W. Effects of Potassium sodium dehydroandroandrographolide succinate injection on rotavirus diarrhea and myocardial enzymes in children. Chin J Microecol (中国微生态学杂志), 2017, 29(12): 1431-1433.
[10] HUANG S T, SU Y H. Influence and curative effect of Trimebutine Maleate combined with Bifid Triple Viable Capsules on intestinal flora of patients with diabetic diarrhea. Chin Commun Doct (中国社区医师), 2018, 34(2): 45-46.
[11] MU Y, SONG Y, NA D. Intestinal microecology and nursing care of postoperative diarrhea patients with rectal cancer. Chin J Microecol (中国微生态学杂志), 2017, 29(4): 431-433.
[12] ZHAO Y, Yu Y B. Intestinal microbiota and chronic constipation. Springerplus, 2016, 5(1): 1-8.
[13] KAJANDER K, MYLLYLUOMA E, RAJILIC-STOJANOVIC M, et al. Clinical trial: mult ispecies probiotic supplementation alleviates the symptoms of irritable bow elsyndrome and stabilizesintestinal microbiota. Aliment Pharmacol Ther, 2008, 27(1): 48-57.
[14] WANG T T, CAI G X, QIU Y P, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J, 2011, 6(2): 320-329.
[15] COLLINS K H, PAUL H A, REIMER R A, et al. Relationship between inflammation, the gut microbiota, and metabolicosteoarthritis development: studies in a rat model. Osteoarthr Cartil, 2015, 23(11): 1989-1998.
[16] ZHAO L P. Genomics:the tale of our other genome. Nature, 2010, 465(7300): 879-880.
[17] PERRY R J, PENG L, BARRY N A, et al. Acetate mediates a microbiome-brain-β cell axis promoting metabolic syndrome. Nature, 2016, 534(7606): 213-217.
[18] LIU R X, HONG J, XU X Q, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med, 2017, 23(7): 859-868.
[19] ISHIMWE N, DALIRI E B, LEE B H, et al. The perspective on cholesterol lowering mechanisms of probiotics. Mol Nutr Food Res, 2015, 59(1): 94-105.
[20] WAN Y, WANG F, YUAN J, et al. Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomized contrlled-feeding trial. Gut, 2019, 68(8): 1417-1429.
[21] EUN A C, HAE C C. Cholesterol-lowering effects of a putative probiotic strain Lactobacillus plantarum EM isolated from kimchi. LWT-Food Sci Technol, 2015, 62(1): 210-217.
[22] TOMAS J, CéLINE M, SAFFARIAN A. High-fat diet modifies the PPAR- γ pathway leading to disruption of microbial and physiological ecosystem in murine small intestine. Proc Natl Acad Sci USA, 2016, 113(40): E5934-E5943.
[23] LUEDDE M. Heart failure is associated with depletion of core intestinal microbiota. Esc Heart Fail, 2017, 4(3): 282-290.
[24] TANG T W, CHEN H C, CHEN C Y, et al. Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair. Circulation, 2019, 139(5): 647-659.
[25] KUMMEN M, MAYERHOFER CRISTIANE CK, VESTAD B, et al. Gut microbiota signature in heart failure defined from profiling of 2 independent cohorts. J Am Coll Cardiol, 2018, 71(10): 1184-1186.
[26] LI J, ZHAO F, WANG Y, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome, 2017, 5(1): 14-32.
[27] LI X, LI C. Analysis of changes in intestinal flora and intrava-scular inflammation and coronary heart disease in obese patients. Exp Ther Med, 2018, 15(5): 4538-4542.
[28] JIE Z Y, XIA H H, ZHONG S L, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun, 2017, 8(1): 845-856.
[29] SENTHONG V, LI X S, HUDEC T, et al. Plasma trimethylamine N-oxide, a gut microbe-generated phosphatidylcholine metabolite, is associated with atherosclerotic burden. J Am Coll Cardiol, 2016, 67(22): 2620-2628.
[30] WU Z X. The changes of gut microbiota after acute myocardial infarction in rats. PLoS One, 2017, 12(7): e0180717. DOI:10.1371/journal.pone.0180717.
[31] RUSSO M, GUIDA F, PAPARO L, et al. The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity. Eur J Heart Fail, 2019, 21(4): 519-528.
[32] PEDERSEN H K, GUDMUNDSDOTTIR V, NIELSEN H B, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature, 2016, 535(612): 376-381.
[33] POIRIER A A, AUBÉ B, CÔTÉ M, et al. Gastrointestinal dysfunctions in parkinson's disease: symptoms and treatments. Parkinson's Dis, 2016, 2016: 1-23. DOI:10.1155/2016/6762528.
[34] STRATI F, CAVALIERI D, ALBANESE D, et al. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome, 2017, 5(1): 24-34.
[35] ZHOU F, LI J Q, ZHOU Y Z, et al. Intestinal microorganisms and aging. Chin Pharm J (中国药学杂志), 2019, 54(10): 761-765.
[36] WOTING A, BLAUT M. The intestinal microbiota in metabolic disease. Nutrients, 2016, 8(4): 202-220.
[37] GREENHILL C. Intestinal microbiota affects host physiology. Nat Rev Endocrinol, 2016, 13(2): 64. DOI:10. 1038/nrendo. 2016. 207.
[38] LYU M, WANG Y F, FAN G W, et al. Balancing herbal medicine and functional food for prevention and treatment of cardiometabolic diseases through modulating gut microbiota. Front Microbiol, 2017, 8: 2146-2166. DOI:10. 3389/fmicb. 2017. 02146.
[39] LIU S Y, KUANG Z Y, ZHANG R, et al. Regulatory effect of baicalin on metaflammation and intestinal flora. J Guangzhou Univ Tradit Chin Med (广州中药大学学报), 2016, 33(3): 372-376.
[40] ZHOU X. Effect of Coptidis Rhizoma and Evodia Rutaecarpa compatibility as equal proportion on cholesterol metabolism related genes and intestinal microbiota in hyperlipidemic rats. Chengdu: Chengdu University of Traditional Chinese Medicine, 2018.
[41] WANG Q, DU Z, ZHANG H, et al. Modulation of gut microbiota by polyphenols from adlay (Coix lacryma-jobi L. var. ma-yuen Stapf.) in rats fed a high-cholesterol diet. Int J Food Sci Nutr, 2015, 66(7): 783-789.
[42] WANG R F, LEI H Y, ZANG P, et al. The effect of rhein on the gut microbiota indiabetes mice. Chin J Microecol (中国微生态学杂志), 2016, 28(1): 21-24,46.
[43] HE K. Rhizoma Coptidis alkaloids exert their anti-hyperlipidemic effects throughmodulation of bile acids signaling and gut microbiota in hyperlipidemia C57BL/6J mice. Chongqing: Southwest University, 2017.
[44] ZHANG X, ZHAO Y F, XU J, et al. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Sci Rep, 2015, 5: 14405-14414. DOI:10.1038/srep14405.
[45] LIU Y Y, ZHANG K, GUAN J W, et al. The effects of ginsenoside on the intestinal microbiota of mice. Prog Mod Biomed (现代生物医学进展), 2015, 15(6): 1041-1045.
[46] XU J, LIAN F M, ZHAO L H, et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula . ISME J, 2015, 9(3): 552-562.
[47] XU J, CHEN H B, LI S L. Understanding the molecular mechanisms of the interplay between herbal medicines and gut microbiota. Med Res Rev, 2017, 37(5): 1140-1185.
[48] SHI L L, WANG Y, FENG Y. Effect of MDG-1, a polysaccharide from Ophiopogon japonicas, on diversity of Lactobacillus in diet-induced obese mice. China J Chin Mater Med (中国中药杂志), 2015, 40(4): 716-721.
[49] KHAN I, HUANG G X, LI X A, et al. Mushroom polysaccharides from Ganoderma lucidum and Poria cocos reveal prebiotic functions. J Funct Foods, 2018, 41: 191-201. DOI:10.1016/j.jff.2017.12.046.
[50] XU S, DOU Y, YE B, et al. Ganoderma lucidum polysaccharides improve insulin sensitivity by regulating inflammatory cytokines and gut microbiota composition in mice. J Funct Foods, 2017, 38: 545-552. DOI:10.1016/j.jff.2017.09.032.
[51] CHANG C J, LIN C S, LU C C, et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun, 2017, 6(1): 74-89.DOI:10.1038/ncomms8489.
[52] HAN K, BOSE S, KIM Y M, et al. Rehmannia glutinosa reduced waist circumferences of Korean obese women possibly through modulation of gut microbiota. Food Funct, 2015, 6(8): 2684-2692.
[53] DENG H, WU C Q, ZHAO C X, et al. Study on relationship between Polygonum multiflorum induced liver injury and gut microbiota by High-throughput sequencing and Real-time PCR. Drug Eval Res (药物评价研究), 2017, 40(4): 464-471.
[54] HE L, LONG C X, LIU Y J, et al. Regulatory effect of Chinese medicine on intestinal digestive enzyme activity. J Chin Med Mater (中药材), 2017, 40(8): 1983-1986.
[55] ZENG H L, XIAO M, CHEN B, et al. Effect of Atractylodes decoction prescription on regulating gut flora and protecting intestine. Mod Food Sci Technol (现代食品科技), 2018(1): 1-7. DOI:10.13982/j.mfst.1673-9078.2018.1.005.
[56] LI J J, LI J G, WEN C, et al. Therapeutical effect of traditional Chinese medicine prescription containing Magolia of ficinalis on antibiotic-associated diarrhea in rats. Pract Pharm Clin Rem (实用药物与临床), 2015, 18(12): 1421-1424.
[57] SUN B Q, WU C R, ZHOU Y, et al. Effects of different formulations of Qiwei Baizhu Powder on the ultrastructure of small intestinal mucosa and sIgA in mice with intestinal dysbacteriosis. Chin J Microecol (中国微生态学杂志), 2016, 28(2): 125-128,137.
[58] ZHANG W P, FENG S N. Influence of the numbers of intestinal flora in mice with diarrhoea by Erzhu Zhixie decoction. Acta Chin Med (中医学报), 2015, 30(11): 1639-1641.
[59] CHEN L L, ZHANG S W, LI D P, et al. Influence of the numbers of intestinal flora in mice with diarrhoea by Erzhu Zhixie decoction. Shaanxi J Tradit Chin Med (陕西中医), 2018, 39(4): 415-418.
[60] FENG Q, LIU W, BAKER S S, et al. Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of nonalcoholic fatty liver disease. Oncotarget, 2017, 8(17): 27820-27838.
[61] ZHANG Y, TANG K, DENG Y, et al. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats. Biomed Pharmacother, 2018, 102: 1025-1036. DOI:10.1016/j.biopha.2018.03.158.
[62] HUSSAIN A, YADAV M K, BOSE S, et al. Daesiho-Tang is an effective herbal formulation in attenuation of obesity in mice through alteration of gene expression and modulation of intestinal microbiota. PLoS One, 2016, 11(11): e0165483. DOI:10.1371/journal.pone.0165483.
[63] LONG C X, HE L, GUO K X, et al. Effects of Qiweibaizhu powder on the intestinal bacterial diversity in dysbacteriotic diarrhea mice. Chin J Integr Tradit West Med (中国中西医结合杂志), 2018, 38(1): 66-70.
[64] LONG C X, LIU Y W, HE L, et al. Bacterial lactase genes diversity in intestinal mucosa of mice with dysbacterial diarrhea induced by antibiotics. 3 Biotech, 2018, 8(3): 176-184.
[65] HE L, LIU Y W, GUO Y F, et al. Diversity of intestinal bacterial lactases gene from antibiotics-induced diarrhea mice treated with Chinese herbs compound Qi Wei Bai Zhu San. 3 Biotech, 2018, 8(1): 4-10.
[66] LIU C,ZHANG C, LV W J, et al. Structural modulation of gut microbiota during alleviation of suckling piglets diarrhoea with herbal formula. Evid-Based Complement Altern Med, 2017, 2017: 1-11. DOI:10.1155/2017/8358151.
[67] FU Z F, YANG L, SHANG F, et al. Research progress on the relationship between polysaccharides of traditional Chinese medicine and type 2 diabetes based on intestinal microbes. Mod Tradit Chin Med Mater Med-World Sci Technol (世界科学技术-中医药现代化), 2019, 21(6): 1110-1117.
[68] GUO M Z, DING S, ZHAO C H, et al. Red ginseng and semen coicis can improve the structure of gut microbiota and relieve the symptoms of ulcerative colitis. J Ethnopharmacol, 2015, 162(10): 7-13. DOI:10.1016/j.jep.2014.12.029.
[69] HAN G Z. Metabolism of drugs in intestinal tract and its influence on drug action . Chin Pharm J (中国药学杂志), 1985, 20(5): 294-296.
[70] WU S, XU W, YANG X W. Studies on biotransformation of chemical constituents of Tongmai formula by human intestinal flora . China J Chin Mater Med (中国中药杂志), 2013, 38(20): 3510-3519.
[71] WU S, ZHOU Q L, YANG X W. UFLC-DAD-ESI-IT-TOFMSn Analysis on biotransformation of Tongmai Formula incubated with human intestinal bacteria . Chin Herb Med, 2017, 9(3): 258-266.
[72] YANG X W, ZHANG L, XU W, et al. Biotransformation of triterpenes in Ginseng Radix et Rhizoma water extract with human intestinal flora incubation system in vitro . Mod Chin Med (中国现代中药), 2021, 23(7): 1172-1181.
[73] ZHANG P, YANG X W. Biotransformation of nodakenin and simultaneous quantification of nodakenin and its aglycone in incubated system of human intestinal bacteria by HPLC method . J Asian Nat Prod Res, 2009, 11(4): 371-379.
[74] RAN L, WU S, XU W, et al. Biotransformation of naringin by human intestinal flora . J Pharm Sci-US, 2013, 22(4): 329-333.
[75] DENG H, WU C Q, JIANG T, et al. Progress in microbiome and its application to pharmacological and toxicological research of traditional Chinese materia medica. Chin J Pharmacol Toxicol (中国药理学与毒理学杂志), 2016, 30(9): 975-982.
[76] ZHANG Z N, CHEN R X, WANG Y F, et al. Interaction of drugs and intestinal flora. J Chin Med Mater (中药材), 2015, 38(6): 1319-1323.
[77] BAE E A, HAN M J, KIM E J, et al. Transformation of ginseng saponins to ginsenoside rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch Pharm Res, 2004, 27(1): 61-67.
[78] LEE N K, CHOI S H, PARK S H, et al. Antiallergic activity of hesperidin is activated by intestinal microflora. Pharmacology, 2004, 71(4): 174-180.
[79] SONG R, XU L, XU F, et al. Metabolic analysis of rhubarb extract by rat intestinal bacteria using liquid chromatography-tandem mass spectrometry. Biomed Chromatogr, 2011, 25(3): 417-426.
[80] MATSUMOTO M, ISHIGE A, YAZAWA Y, et al. Promotion of intestinal peristalsis by Bifidobacterium spp. capable of hydrolysing sennosides in mice. PLoS One, 2012, 7(2): e31700.DOI:10.1371/journal.pone.0031700.
[81] CHENG W W, LU J, LI B X, et al. Effect of functional oligosaccharides and ordinary dietary fiber on intestinal microbiota diversity. Front Microbiol, 2017, 8: 1750-1760. DOI:10.3389/fmicb.2017.01750.
[82] ZHANG T H, YANG Y, LIANG Y, et al. Beneficial effect of intestinal fermentation of natural polysaccharides. Nutrients, 2018, 10(8): 1055-1076.
[83] JIANG W Y, GAO L, LI P D, et al. Metabonomics study of the therapeutic mechanism of fenugreek galactomannan on diabetic hyperglycemia in rats, by ultra- performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. J Chromatogr B, 2017, 1044/1045: 8-16. DOI:10.1016/j.jchromb.2016.12.039.
[84] GAO X, GENG T, MA Y, et al. Metabolism of six saponins by rat intestinal bacteria in vitro. China J Chin Mater Med (中国中药杂志), 2016, 41(12): 2329-2338.
[85] QUAN Y Y, YUAN A, GONG X H, et al. Investigation on anti-inflammatory components of Forsythia suspensa. Nat Prod Res Dev (天然产物研究与开发), 2017, 29: 435-438,471. DOI:10.16333/j.1001-6880.2017.3.013.
[86] HAISER H J, GOOTENBERG D B, CHATMAN K A, et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science, 2013, 341(6143): 295-298.
[87] GONG C Y, XIAO W, WANG Z Z, et al. Stability of akebia saponin D in gastrointestinal contents of rats. China J Chin Mater Med (中国中药杂志), 2014, 39(2): 2311-2313.
[88] NAKAMURA K, NISHIHATA T, JIN J S, et al. The C-glucosyl bond of puerarin was cleaved hydrolytically by a human intestinal bacterium strain PUE to yield its aglycone daidzein and an intact glucose. Chem Pharm Bull, 2011, 59(1): 23-27.
[89] WU K H, TANG L Y, WANG Z J, et al. Advances in studies on chemical constituents and bioactivities of Aconitum carmichaeli. Chin J Exp Tradit Med Form (中国实验方剂学杂志), 2014, 20(2): 212-220.
[90] ZHAO Y F, SONG F R, GUO X H, et al. Studies on the biotransformation of aconitine in human intestinal bacteria using soft ionization mass spectrometry. Chem J Chin Univ (高等学校化学学报), 2008, 29(1): 55-59.
[91] LYU J Z, DENG J G. Research progress in pharmacological effects of amygdalin. Drugs Clin (现代药物与临床), 2012, 27(5): 530-535.
[92] AKYILDIZ B N, KURTOGLU B N, KONDOLOT M, et al. Cyanide poisoning caused by ingestion of apricot seeds . Ann Trop Paediatr, 2010, 30: 39-43. DOI:10. 1179/146532810X12637 745451951.